The Physiological Impact of CTO PCI on Coronary Pressure Measurements and Correlation in Donor Vessel (IMPACT-CTO)

December 20, 2021 updated by: Mid and South Essex NHS Foundation Trust

The Physiological IMPACT of Coronary Chronic Total Occlusion (CTO) Percutaneous Coronary Intervention (PCI) on Coronary Pressure --Derived Measurements, Its Correlation in the Donor Vessel and the Influence of Collateral Circulation

This study will be recording pressure wire readings from both blocked and narrowed arteries, to better guide treatment options; medications, stents or potentially bypass surgery, for patients with Chronic Total Occlusion (CTO).

Study Overview

Status

Completed

Detailed Description

The patients in this study are planned to have a Percutaneous Coronary Intervention (PCI) with recanalization of Chronic Total Occlusion (CTO) on clinical grounds alone.

This study will be recording pressure wire readings from both blocked and narrowed arteries, to better guide treatment option. To date there is no data available on instantaneous wave free ratio (iFR) measurement (a pressure derived assessment of flow limitation) in patients with blocked arteries.

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Essex
      • Basildon, Essex, United Kingdom, SS16 5NL
        • The Essex Cardiothoracic Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients scheduled for a PCI CTO

Description

Inclusion Criteria:

  1. Age >18 years of age
  2. Stable angina / ischaemic symptoms
  3. Evidence of viability and / or ischaemia in the chronic total occlusion (CTO) territory
  4. Participant is willing and able to give informed consent for participation in the study
  5. Presence of a chronic total occlusion (CTO) in RCA:

    • Duration of the occlusion > 3 months;
    • Thrombolysis In Myocardial Infarction (TIMI) (50) coronary flow grade 0;
    • Spontaneously visible collaterals, Rentrop classification grade 1 or 2 or 3 from contralateral donor artery
  6. Presence of minor to intermediate coronary stenosis (1-70 %) in the contralateral donor artery
  7. Eligible for PCI to a chronic total occlusion (CTO)

Exclusion Criteria:

  1. Previous CABG with patent grafts to the interrogated donor artery
  2. Left main stenosis of > 40 %
  3. Presence of severe flow limiting stenosis in the contralateral donor artery (typically > 70 % stenosis)
  4. Haemodynamic instability at the time of intervention (heart rate <40 beats per minute, systolic blood pressure <90mmHg), balloon pump)
  5. Significant contraindication to adenosine administration (e.g. heart block, severe asthma)
  6. Contraindications to PCI
  7. Severe hepatic or lung disease (chronic pulmonary obstructive disease)
  8. Pregnancy
  9. ACS within 48 hours of procedure
  10. Severe valvular heart disease
  11. Severe cardiomyopathy / Infiltrative heart disease
  12. eGFR < 40

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Coronary pressure changes
Time Frame: 5 Minutes
Changes in coronary pressure - derived measurements (resting Pd/Pa, iFR and FFR) in donor artery pre and post RCA CTO PCI
5 Minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Population correlation
Time Frame: 5 minutes
Correlation between coronary pressure---derived measurements in this population.
5 minutes
Donor artery correlation
Time Frame: 5 minutes
Correlation between collateral circulation function on coronary pressure - derived measurements in donor artery pre and post RCA CTO PCI.
5 minutes
Cardiac MRI correlation
Time Frame: 5 minutes
Correlation between baseline coronary pressure - derived measurements in donor artery pre RCA CTO PCI, collateral circulation indices and baseline non-invasive functional assessment /Cardiac MRI (CMR)
5 minutes
Effects of stenosis severity (QCA)
Time Frame: 5 minutes
Effects of stenosis severity (QCA) in donor artery on coronary pressure-derived measurements
5 minutes
Collateral circulation characteristics
Time Frame: 5 minutes
Influence of collateral circulation characteristics on coronary pressure-derived measurements
5 minutes
Coronary pressure and jeopardy scores correlation
Time Frame: 5 minutes
Correlation between coronary pressure-derived measurements in the donor artery and myocardial jeopardy scores in the donor artery
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas Keeble, MBBS MRCP, The Essex Cardiothoracic Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2015

Primary Completion (Actual)

May 31, 2018

Study Completion (Actual)

May 31, 2018

Study Registration Dates

First Submitted

December 22, 2015

First Submitted That Met QC Criteria

December 30, 2015

First Posted (Estimate)

December 31, 2015

Study Record Updates

Last Update Posted (Actual)

January 11, 2022

Last Update Submitted That Met QC Criteria

December 20, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Subscribe